Bornemann Kellee, Croswell Emilee, Abaye Menna, Bryce Cindy L, Chang Chung-Chou H, Good Deborah S, Freehling Heiles Cathleen A, Dew Mary Amanda, Boulware L Ebony, Tevar Amit D, Myaskovsky Larissa
Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States; Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States.
Contemp Clin Trials. 2017 Feb;53:52-59. doi: 10.1016/j.cct.2016.11.011. Epub 2016 Dec 5.
Living donor kidney transplantation (LDKT) is the optimal treatment for end-stage kidney disease (ESKD). The evaluation process for a kidney transplant is complex, time consuming, and burdensome to the ESKD patient. Also, race disparities exist in rates of transplant evaluation completion, transplantation, and LDKT. In December 2012 our transplant center implemented a streamlined, one-day evaluation process, dubbed Kidney Transplant Fast Track (KTFT). This paper describes the protocol of a two-part study to evaluate the effectiveness of KTFT at increasing transplant rates (compared to historical controls) and the TALK intervention (Talking About Live Kidney Donation) at increasing LDKT during KTFT. All participants will receive the KTFT evaluation as part of their usual care. Participants will be randomly assigned to TALK versus no-TALK conditions. Patients will undergo interviews at pre-transplant work-up and transplant evaluation. Transplant status will be tracked via medical records. Our aims are to: (1) test the efficacy and cost effectiveness of the KTFT in reducing time to complete kidney transplant evaluation, and increasing kidney transplant rates relative to standard evaluation practices; (2) test whether TALK increases rates of LDKT during KTFT; and (3) determine whether engaging in a streamlined and coordinated-care evaluation experience within the transplant center reduces negative perceptions of the healthcare system. The results of this two-pronged approach will help pave the way for other transplant centers to implement a fast-track system at their sites, improve quality of care by transplanting a larger number of vulnerable patients, and address stark race/ethnic disparities in rates of LDKT.
活体供肾移植(LDKT)是终末期肾病(ESKD)的最佳治疗方法。肾移植的评估过程复杂、耗时,给ESKD患者带来负担。此外,在移植评估完成率、移植率和LDKT方面存在种族差异。2012年12月,我们的移植中心实施了一个简化的一日评估流程,称为肾移植快速通道(KTFT)。本文描述了一项分为两部分的研究方案,以评估KTFT在提高移植率(与历史对照组相比)方面的有效性,以及TALK干预措施(谈论活体肾捐赠)在KTFT期间提高LDKT方面的有效性。所有参与者将接受KTFT评估作为其常规护理的一部分。参与者将被随机分配到TALK组和非TALK组。患者将在移植前检查和移植评估时接受访谈。通过医疗记录跟踪移植状态。我们的目标是:(1)测试KTFT在缩短完成肾移植评估时间以及相对于标准评估做法提高肾移植率方面的疗效和成本效益;(2)测试TALK在KTFT期间是否能提高LDKT率;(3)确定在移植中心参与简化和协调护理评估体验是否能减少对医疗系统的负面看法。这种双管齐下方法的结果将有助于为其他移植中心在其所在地实施快速通道系统、通过移植更多弱势患者提高护理质量以及解决LDKT率方面明显的种族/族裔差异铺平道路。